Introduction:
This article discusses the use of high-resolution isoelectric focusing (icIEF) fractionation combined with liquid chromatography-mass spectrometry (LC-MS) analysis to characterize adeno-associated virus (AAV) charge heterogeneity. AAVs are widely used as gene therapy vectors, and their physicochemical properties, such as charge heterogeneity, can affect their therapeutic efficacy and safety. Understanding and characterizing AAV charge heterogeneity is crucial for the development and manufacturing of effective and safe gene therapies.
- This study utilized high-resolution icIEF fractionation combined with LC-MS analysis to characterize AAV charge heterogeneity.
- icIEF allows for the separation of AAV variants based on their isoelectric points, providing detailed information about the charge distribution and heterogeneity.
- LC-MS analysis further enhances the characterization by identifying the specific charge variants and providing quantitative data.
- The results of this study revealed the presence of multiple charge variants in AAV samples, highlighting the importance of characterizing and controlling charge heterogeneity in gene therapy manufacturing.
- Understanding AAV charge heterogeneity can aid in process development, quality control, and regulatory approval of gene therapies.
Conclusion:
This study demonstrates the use of high-resolution icIEF fractionation with LC-MS analysis as a powerful tool for characterizing AAV charge heterogeneity. The characterization of AAV charge variants can provide insights into their physicochemical properties and help optimize manufacturing processes to ensure consistent and high-quality gene therapies. This research contributes to the ongoing efforts in the field of gene therapy development and highlights the importance of comprehensive characterization techniques in ensuring the safety and efficacy of gene therapies.
